Women who develop diabetes before or during pregnancy are likelier to experience perinatal depresssion.
Women who develop diabetes either prior to or during pregnancy are more likely to experience perinatal depression, including postpartum depression, researchers report in the Feb. 25 issue of the Journal of the American Medical Association.
Katy Backes Kozhimannil, of Harvard Medical School in Boston, and colleagues retrospectively assessed a cohort of 11,024 women who gave birth between 2004 and 2006. All women were also enrolled in Medicaid from 6 months prior to 1 year after delivery.
Of the entire sample population, women who had either prepregnancy or gestational diabetes were nearly twice as likely to have depression either during pregnancy or postpartum compared with women having no diabetes (15.2% versus 8.5%), the investigators found. This increased risk (1.85-fold) was apparent even after adjusting for age, race, delivery year, or gestational age at birth, the report indicates. Even women with no prenatal indication of depression were 69% more likely to experience postpartum depression or take antidepressant medication if they had diabetes, the researchers note.
“To our knowledge, our study is the first to present data on the association between diabetes and depression during the perinatal period,” the authors write. “Treatable, perinatal depression is underdiagnosed, and it is important to target detection and support efforts toward women at high risk.”
Kozhimannil KB, Pereira MA, Harlow BL. Association between diabetes and perinatal depression among low-income mothers. JAMA. 2009;301:842-847.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More